Curis reported $12.15M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US $ 12618M 268M
AstraZeneca AZN:LN 21815M 925M
Bayer BAYN:GR € 33643M 2624M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Chimerix CMRX:US $ 23.27M 8.06M
Curis CRIS:US $ 12.15M 2.46M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Epizyme EPZM:US $ 34.95M 4.01M
Exelixis EXEL:US $ 304.52M 15.44M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 37835M 13557M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Novartis NOVN:VX SF 27646M 2161M
Spectrum Pharmaceuticals SPPI:US $ 41.04M 1.83M
Takeda 4502:JP Y 2166942M 21212M
Verastem VSTM:US $ 20.09M 3.21M
Xoma XOMA:US $ 8.42M 534K
YTE INCY:US $ 926.67M 40.51M
Ziopharm Oncology ZIOP:US $ 26.78M 5.54M